Beijing Beilu Pharmaceutical Company Description

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China.

The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules.

It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents comprising iohexol, ioversol, iodixanol, iopromide, and iopamidol, as well as oral anti-diabetic drugs.

The company was founded in 1992 and is headquartered in Beijing, China.

Beijing Beilu Pharmaceutical Co., Ltd

Country	China
Founded	1992
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,173
CEO	Xu Wang

Contact Details

Address: Maples International Office Beijing, 100082 China
Phone	86 10 6262 2266
Website	beilu.com.cn

Stock Details

Ticker Symbol	300016
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE000001QK9
SIC Code	2834

Key Executives

Name	Position
Xu Wang	Chairman and GM
Ni Zeng C.P.A.	Deputy GM, Chief Financial Officer, Accounting Supervisor and Non-Independent Director
Sen Li	Executive Vice President and Chief Operating Officer
Li Zong	Deputy GM and Director
Zehui Shao	Deputy GM, Secretary of the Board of Directors and Non-Independent Director
Xiasi Kuang	Deputy General Manager
Gen Chang Zheng	Chief Engineer and Employee Representative Member of Supervisory Board